These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26698882)

  • 1. Meta-Analysis of Renal Function on the Safety and Efficacy of Novel Oral Anticoagulants for Atrial Fibrillation.
    Del-Carpio Munoz F; Gharacholou SM; Munger TM; Friedman PA; Asirvatham SJ; Packer DL; Noseworthy PA
    Am J Cardiol; 2016 Jan; 117(1):69-75. PubMed ID: 26698882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis.
    Hijazi Z; Hohnloser SH; Oldgren J; Andersson U; Connolly SJ; Eikelboom JW; Ezekowitz MD; Reilly PA; Siegbahn A; Yusuf S; Wallentin L
    Circulation; 2014 Mar; 129(9):961-70. PubMed ID: 24323795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of nonvitamin K antagonist oral anticoagulants versus warfarin in diabetic patients with atrial fibrillation: A study-level meta-analysis of phase III randomized trials.
    Patti G; Di Gioia G; Cavallari I; Nenna A
    Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 28029216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: a meta-analysis of 50,578 patients.
    Capodanno D; Capranzano P; Giacchi G; Calvi V; Tamburino C
    Int J Cardiol; 2013 Aug; 167(4):1237-41. PubMed ID: 22494863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the New Oral Anticoagulants and Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Systematic Review and Meta-Analysis.
    de Souza Lima Bitar Y; Neto MG; Filho JAL; Pereira LV; Travassos KSO; Akrami KM; Roever L; Duraes AR
    Drugs R D; 2019 Jun; 19(2):117-126. PubMed ID: 31055767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left Atrial Appendage Occlusion Device and Novel Oral Anticoagulants Versus Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Briceno DF; Villablanca P; Cyrille N; Massera D; Bader E; Manheimer E; Aagaard P; Ferrick K; Gross J; Kim SG; Krumerman A; Palma E; Guttenplan N; Romero J; Fisher J; Garcia M; Natale A; Di Biase L
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1057-64. PubMed ID: 26226997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding of new oral anticoagulants for stroke prevention in atrial fibrillation: a meta-analysis of randomized controlled trials.
    Kwong JS; Lam YY; Yan BP; Yu CM
    Cardiovasc Drugs Ther; 2013 Feb; 27(1):23-35. PubMed ID: 23224686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Oral Anticoagulants in Patients With Atrial Fibrillation and Stages 4 or 5 Chronic Kidney Disease.
    Chang SH; Wu CV; Yeh YH; Kuo CF; Chen YL; Wen MS; See LC; Huang YT
    Am J Med; 2019 Nov; 132(11):1335-1343.e6. PubMed ID: 31278930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of non-vitamin K antagonist oral anticoagulants and warfarin on clinical outcomes in atrial fibrillation patients with renal dysfunction.
    Lee KH; Park HW; Cho JG; Yoon NS; Kim SS; Kim MR; Kim MC; Cho KH; Kim HK; Kim CH; Kim KH; Jun SJ; Kim WJ; Lee KJ; Jeong HC; Cho JY; Park KH; Sim Ds; Yoon HJ; Kim KH; Hong YJ; Kim JH; Ahn Y; Jeong MH; Park JC
    Europace; 2015 Oct; 17 Suppl 2():ii69-75. PubMed ID: 26842118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of oral anticoagulants in warfarin-suitable patients with nonvalvular atrial fibrillation: systematic review and meta-analysis.
    Mitchell SA; Simon TA; Raza S; Jakouloff D; Orme ME; Lockhart I; Drost P
    Clin Appl Thromb Hemost; 2013; 19(6):619-31. PubMed ID: 23698729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Safety Outcomes of Oral Antithrombotics for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Network Meta-analysis.
    Lin L; Lim WS; Zhou HJ; Khoo AL; Tan KT; Chew AP; Foo D; Chin JJ; Lim BP
    J Am Med Dir Assoc; 2015 Dec; 16(12):1103.e1-19. PubMed ID: 26527225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease: A Meta-Analysis and Systematic Review.
    Fu Y; Zhu W; Zhou Y; Chen H; Yan L; He W
    Am J Cardiovasc Drugs; 2020 Apr; 20(2):139-147. PubMed ID: 31485852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease.
    Renda G; Ricci F; Giugliano RP; De Caterina R
    J Am Coll Cardiol; 2017 Mar; 69(11):1363-1371. PubMed ID: 28302287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription patterns of oral anticoagulants for patients with non-valvular atrial fibrillation: experience at a Japanese single institution.
    Tagaya M; Yoshikawa D; Sugishita Y; Yamauchi F; Ito T; Kamada T; Yoshinaga M; Mukaide D; Fujiwara W; Yokoi H; Hayashi M; Watanabe E; Ishii J; Ozaki Y; Izawa H
    Heart Vessels; 2016 Jun; 31(6):957-62. PubMed ID: 26022376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis.
    Bai Y; Guo SD; Deng H; Shantsila A; Fauchier L; Ma CS; Lip GYH
    Age Ageing; 2018 Jan; 47(1):9-17. PubMed ID: 28985259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal function and risk of stroke and bleeding in patients undergoing catheter ablation for atrial fibrillation: Comparison between uninterrupted direct oral anticoagulants and warfarin administration.
    Yanagisawa S; Inden Y; Fujii A; Ando M; Funabiki J; Murase Y; Takenaka M; Otake N; Ikai Y; Sakamoto Y; Shibata R; Murohara T
    Heart Rhythm; 2018 Mar; 15(3):348-354. PubMed ID: 29107192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-vitamin K antagonist oral anticoagulants have better efficacy and equivalent safety compared to warfarin in elderly patients with atrial fibrillation: A systematic review and meta-analysis.
    Kim IS; Kim HJ; Kim TH; Uhm JS; Joung B; Lee MH; Pak HN
    J Cardiol; 2018 Aug; 72(2):105-112. PubMed ID: 29519547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation].
    Di Lullo L; Barbera V; Bellasi A; Cozzolino M; Russo D; Otranto G; Santoboni F; Ronco C
    G Ital Nefrol; 2017 Apr; 34(2):58-73. PubMed ID: 28682563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
    Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of non-vitamin K antagonist oral anticoagulants versus warfarin in heart failure patients with atrial fibrillation.
    Chen F; Zhou Y; Wan Q; Yu P; Ma J; Hu J
    Heart Fail Rev; 2021 Nov; 26(6):1391-1397. PubMed ID: 32249407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.